Cetuximab, fluorouracil ( 5-FU) and cisplatin alone or with docetaxel in recurrent and/or metastatic head and neck cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2015
At a glance
- Drugs Docetaxel (Primary) ; Cetuximab; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 28 Feb 2015 Status changed from recruiting to completed as reported by European Clinical Trial database.
- 03 Jun 2014 Primary endpoint has not been met. (Progression-free survival)
- 03 Jun 2014 First analysis findings presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History